ARQTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Arcutis Biotherapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$31.89+3.07 (+10.65%)
Close on Oct 19, 2026
- Market cap
- $4.33B
- P/E (TTM)
- 145.0
- Dividend yield
- –
SEC filings
40 of Arcutis Biotherapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2026 | Jul 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 21, 2026 | Apr 21, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 25, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2026 | Feb 25, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 3, 2025 | Dec 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 28, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 28, 2025 | Oct 28, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2025 | Apr 10, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2025 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2025 | Jan 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 14, 2024 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Mar 31, 2024 | Jul 24, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 14, 2024 | Jun 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 14, 2024 | SEC EDGAR |
| Current report | 8-K | May 14, 2024 | May 14, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 26, 2024 | Apr 26, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2024 | Apr 10, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 28, 2024 | Mar 4, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2024 | Feb 28, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 27, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2024 | Feb 27, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2024 | Feb 15, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 11, 2024 | Jan 11, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 15, 2023 | Dec 18, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 3, 2023 | SEC EDGAR |